1. Home
  2. BDSX vs RCAT Comparison

BDSX vs RCAT Comparison

Compare BDSX & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • RCAT
  • Stock Information
  • Founded
  • BDSX 2005
  • RCAT 2002
  • Country
  • BDSX United States
  • RCAT United States
  • Employees
  • BDSX N/A
  • RCAT N/A
  • Industry
  • BDSX Precision Instruments
  • RCAT Wholesale Distributors
  • Sector
  • BDSX Health Care
  • RCAT Industrials
  • Exchange
  • BDSX Nasdaq
  • RCAT Nasdaq
  • Market Cap
  • BDSX 245.3M
  • RCAT 248.8M
  • IPO Year
  • BDSX 2020
  • RCAT 2017
  • Fundamental
  • Price
  • BDSX $1.62
  • RCAT $3.60
  • Analyst Decision
  • BDSX Strong Buy
  • RCAT Strong Buy
  • Analyst Count
  • BDSX 4
  • RCAT 1
  • Target Price
  • BDSX $3.08
  • RCAT $4.00
  • AVG Volume (30 Days)
  • BDSX 254.1K
  • RCAT 2.1M
  • Earning Date
  • BDSX 11-05-2024
  • RCAT 09-23-2024
  • Dividend Yield
  • BDSX N/A
  • RCAT N/A
  • EPS Growth
  • BDSX N/A
  • RCAT N/A
  • EPS
  • BDSX N/A
  • RCAT N/A
  • Revenue
  • BDSX $60,902,000.00
  • RCAT $18,864,788.00
  • Revenue This Year
  • BDSX $48.06
  • RCAT $82.78
  • Revenue Next Year
  • BDSX $29.97
  • RCAT N/A
  • P/E Ratio
  • BDSX N/A
  • RCAT N/A
  • Revenue Growth
  • BDSX 46.25
  • RCAT 259.85
  • 52 Week Low
  • BDSX $1.15
  • RCAT $0.53
  • 52 Week High
  • BDSX $2.21
  • RCAT $3.94
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 38.11
  • RCAT 65.26
  • Support Level
  • BDSX $1.62
  • RCAT $3.11
  • Resistance Level
  • BDSX $1.72
  • RCAT $3.94
  • Average True Range (ATR)
  • BDSX 0.05
  • RCAT 0.34
  • MACD
  • BDSX -0.01
  • RCAT 0.07
  • Stochastic Oscillator
  • BDSX 0.00
  • RCAT 88.11

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a military technology company that integrates robotic hardware and software to provide critical situational awareness and actionable intelligence to on-the-ground warfighters and battlefield commanders. Its mission is to enhance the effectiveness and safety of military operations domestically and globally. Red Cat's suite of solutions includes Teal Drones, developer of the Golden Eagle, a small unmanned system with the highest resolution imaging for night-time operations, and Skypersonic, a provider of unmanned aircraft for interior spaces and other dangerous environments.

Share on Social Networks: